Kidney International Reports

Article	Citations
POS-652 THE DIRECT COST OF DIALYSIS IN SRI LANKA	177
Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?	150
Epigenome-Wide Association Studies of DNA Methylation in Kidney Diseases	118
POS-253 THE RELATIONSHIP BETWEEN THE NEUTROPHILS / LYMPHOCYTES RATIO AND THE PLATELETS / LYMPHOCYTES RATIO WITH THE OCCURRENCE OF CARDIOVASCULAR COMPLICATIONS IN HEMODIALYSIS PATIENTS	100
POS-260 Polycystic kidney disease in Chad: about 26 cases	98
POS-336 SEMAGLUTIDE 2.4 MG AND 1.0 MG IMPROVED ALBUMINURIA IN ADULTS WITH OVERWEIGHT/OBESITY AND TYPE 2 DIABETES IN STEP 2	77
POS-466 THE CRITICAL ROLE OF A NEPHROLOGIST IN KIDNEY STONES: A TALE OF PRIMARY HYPEROXALURIA	76
POS-206 Subphenotyping using combined biomarkers and clinical data reveals novel patterns within high-risk patients with diabetic kidney disease	75
POS-074 Recurrent subcutaneous Phaeohyphomycosis with bone involvement after kidney transplant: A case report	64
POS-187 PROGNOSTIC ROLES OF URINARY TUBULAR INJURY MARKERS IN DIABETIC NEPHROPATHY	64
POS-084 OUTCOMES OF BIOPSY PROVEN BKV NEPHROPATHY POST KIDNEY TRANSPLANT – A SINGLE CENTRE EXPERIENCE	58
WCN23-0377 THE ROLE OF INTRA-CATHETER TAUROLIDINE IN PREVENTING RELAPSING AND REPEAT PERITONEAL DIALYSIS-RELATED PERITONITIS	57
WCN23-0894 APPLICATION OF KDQOL SF- V 1.3 IN OLDER PATIENTS WHO MADE PREVALENT HEMODIALYSIS	52
WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY	49
POS-237 Prevalence and risk factors of anemia among non-dialysis chronic kidney disease patients: a single-centre, cross-sectional study from Malaysia	48
WCN23-0355 A SEASON OF ACUTE KIDNEY INJURY POST BREAST AUGMENTATION	46
POS-240 CGAS/STING DECREATES RENAL FIBROSIS AND INFLAMMATORY RESPONSE INDUCED BY HYPERTENSION BY REGULATING GLUTATHINE METABOLISN	46
POS-216 OUTCOME AMONG ELDERLY WITH ADVANCED KIDNEY DISEASE MANAGED NON-DIALYSIS VERSUS DIALYSIS. A SINGLE CENTRE EXPERIENCE	46
POS-605 THE RELEVANCE OF A GERIATRIC ASSESSMENT IN ELDERLY HEMODIALYSIS PATIENTS	45
POS-611 HEMODIALYSIS TUNNELED-CATHETER RELATED INFECTIONS: RETROSPECTIVE STUDY IN PUBLIC CENTER OF DAKAR	44
POS-328 SUPPRESSION OF ER-ASSOCIATED DEGRADATION BY INTRAGLOMERULAR CROSS-COMMUNICATION BETWEEN MESANGIAL CELLS AND PODOCYTES CAUSES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE	44
POS-125 PERSISTENT MACROSCOPIC HAEMATURIA IN SYSTEMIC ERYTHEMATOSUS	43
POS-321 A RARE NON DIABETIC GLOMERULAR DISEASE IN DIABETIC	43
POS-429 HYPERTENSION IN TUNISIAN ADULTS WITH POLYCYSTIC KIDNEY DISEASE : A RETROSPECTIVE COHORT OF 74 CASES	42
WCN23-0525 A new therapeutic strategy in severe IgA nephropathy by MP pulse and SVF	42

POS-402 UNCOUPLING PROTEIN 1 (UCP1) INHIBITS EPITHELIAL MESENCHYMAL TRANSFORMATION AND EXTRACELLULAR MATRIX AGGREGATION IN RENAL INTERSTITIAL FIBROSIS THROUGH SIRT3 DEPENDENT REACTIVE OXYGEN SPECIES (	42
POS-123 Determinants of Outcome in Crescentic Glomerulonephritis: A Retrospective Study of 78 patients from Tunisia, North Africa	42
WCN23-0582 ECULIZUMAB FOR BEVACIZUMAB-INDUCED THROMBOTIC MICROANGIOPATHY	41
WCN23-0334 VITAMIN D LEVEL IN SLE PATIENTS WITH OR WITHOUT RENAL INVOLVEMENT AND IT’S RELATIONSHIP WITH DISEASE ACTIVITY (SLEDAI SCORE)	40
POS-439 The PROPKD score affect renal involvement in patients with tolvaptan-treated autosomal dominant polycystic kidney disease ?	40
POS-628 COMPARISON OF CITRATE ANTICOAGULATION STRAGEGIES IN HEMODIALYSIS PATIENTS AT HIGH RISK OF BLEEDING: A MUTICENTER PROSPECTIVE OBSERVATIONAL COHORT STUDY	40
WCN23-0427 COENZYME Q10 SUPPLEMENTATION IN AN ADULT PATIENT WITH COQ8 MUTATION AND NEPHROTIC SYNDROME ALLEVIATES RENAL FUNCTION DETERIORATION AND REMITS PROTEINURIA	39
WCN23-1170 ASSOCIATION OF ANGIOTENSINOGEN GENE POLYMORPHISM WITH NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS OF BANGLADESH	37
POS-133 CASE REPORT OF DISSEMINATED KLEBSIELLA INFECTION IN T2DM LEADING TO CKD	36
POS-245 THROMBOMODULIN ACTIVATION DRIVEN BY LIVER X RECEPTOR AGONIST T0901317 ATTENUATES RENAL INFLAMMATION IN DIABETIC NEPHROPATHY	36
WCN23-0726 UREA REDUCTION IN ACUTE KIDNEY INJURY AND MORTALITY RISK	36
WCN23-1177 Practice patterns of Chronic Kidney Disease Screening and Monitoring in Brazil: A Nationwide Laboratory-based Analysis	35
POS-562 A NEW MANAGEMENT METHOD OF METABOLISM OF MINERAL AND BONE FOUNDING BY MACHINE LEARNING IN HEMODIALYSIS PATIENTS	35
WCN23-0378 STUDY OF CLINICAL OUTCOME AND FOLLOW-UP OF MALE LUPUS NEPHRITIS IN A TERTIARY CARE CENTER	35
WCN23-0285 Acute Kidney Disease in the Outpatient Setting: A Hidden Burden Detected by the Integrated National and Institutional Electronic Medical Records Exchange Platform	34
POS-691 CLINICAL OUTCOME OF PERITONEAL DIALYSIS CATHETER REMOVAL AND REINSERTION VIA MODIFIED SELDINGER TECHNIQUE ' THE SERDANG-UPM METHOD'	34
POS-008 EXTRARENAL MANIFESTATIONS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: CARDIAC AND LUNG INVOLVEMENT	34
POS-834 SPONTANEOUS RESOLUTION OF LARGE PERICARDIAL EFFUSION AFTER CARDIOPULMONARY RESUSCITATION IN A CHRONIC KIDNEY DISEASE PATIENT ON MAINTENANCE HAEMODIALYSIS	34
WCN23-1059 OUTCOME OF ATYPICAL HEMOLYTIC UREMIC SYNDROME IN ADULT : A SINGLE CENTER STUDY IN TAIWAN	33
POS-830 DEMOGRPAHICS AND LONG-TERM OUTCOMES OF CHILDREN WITH END-STAGE KIDNEY DISEASE: A 20-YEAR TERRITORY-WIDE STUDY	33
WCN23-0258 SHORT-CHAIN FATTY ACIDS DIRECTLY EXERT ANTI-INFLAMMATORY RESPONSES IN PODOCYTES AND TUBULAR EPITHELIAL CELLS EXPOSED TO HIGH GLUCOSE	33
POS-263 SEXUAL DISORDERS IN PATIENTS WITH CHRONIC RENAL FAILURE	32
POS-912 EFFECTIVENESS OF SARS-COV 2 VACCINATION IN KIDNEY TRANSPLANT PATIENTS IN CHILE	32
WCN23-0905 SYSTEMATIC MICROBIOME DYSBIOSIS ARE ASSOCIATED WITH IGA NEPHROPATHY	32
POS-018 PHASE CONTRAST MAGNETIC RESONANCE IMAGING TO ASSESS RENAL PERFUSION IN PATIENTS WITH C3 GLOMERULOPATHY OR IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	32
POS-036 A YOUNG FEMALE WITH RENAL CORTICAL NECROSIS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN IN A RESOURCE POOR SETTING: CASE REPORT	31
POS-065 DISSEMINATED TUBERCULOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A RARE PRESENTATION AS A PULMONARY-RENAL SYNDROME	31
WCN23-0212 LIRAGLUTIDE IMPROVES BOTH DIABETIC NEPHROPATHY AND CARDIOMYOPATHY IN THE SDT FATTY RAT, A CARDIORENAL MODEL OF TYPE 2 DIABETES	31
POS-484 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME: AN UNDERRECOGNIZED MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS	31
WCN23-1008 PAEDIATRIC RENAL TRANSPLANTATION : EXPERIENCE OF A CENTER	30
WCN23-1106 POLYOMAVIRUS TYPE BK-ASSOCIATED NEPHROPATHY IN A NON-KIDNEY TRANSPLANT RECIPIENT	30
WCN23-0687 CHANGES OF MEDICAL COSTS AND NUMBER OF USES FOR CONTINUOUS RENAL REPLACEMENT THERAPY UNTIL RECENT SIX YEARS IN SOUTH KOREA	30
POS-072 HEMODIALYSIS TUNNELED-CATHETER RELATED INFECTIONS: RETROSPECTIVE STUDY IN PUBLIC CENTER OF DAKAR (2017-2020)	30
POS-640 MACHINE LEARNING FOR INTRADIALYTIC HYPOTENSION PREDICTION IN HAEMODIALYSIS PATIENTS	29
WCN23-0138 Can a Kidney Failure Patient survive with one to two hemodialysis sessions per month for more than 5 years?	29
WCN23-0435 UREMIC PERICARDITIS IN CHRONIC END-STAGE RENAL DISEASE: EXPERIENCE OF THE IBN ROCHD UNIVERSITY HOSPITAL	29
POS-140 DEVELOPMENT OF CHRONIC KIDNEY DISEASE FROM SNAKE BITE INDUCED ACUTE KIDNEY INJURY- RISK ASSESSMENT	28
POS-837 PARATHYROIDECTOMY IS ASSOCIATED WITH SLOW PROGRESSION OF VASCULAR CALCIFICATION IN MAINTENANCE HEMODIALYSIS PATIENTS: A PROPENSITY SCORE-MATCHED CASE-CONTROL STUDY	28
WCN23-0567 PERTURBATIONS IN FREQUENCY AND FUNCTION OF CLASSICAL AND EXHAUSTED MEMORY B CELLS IN LUPUS NEPHRITIS	28
POS-001 Mitochondrial enzymes infused into the kidney under hydrodynamic pressures significantly improves creatinine and BUN levels at the onset of moderate and severe acute kidney injuries	28
POS-630 RELIABILITY OF NEPHROLOGIST LED CLINICAL ASSESSMENT FOR VASCULAR ACCESS CREATION	28
WCN23-0159 ENPP6 IS A POTENTIAL NOVEL CANDIDATE GENE FOR MONOGENIC CONGENITAL ANOMALIES OF THE KIDNEYS AND URINARY TRACT	28
POS-014 NEPHROLOGY REFERRAL PATTERN AND SHORT-TERM OUTCOMES IN COVID 19 POSITIVE PATIENTS	28
POS-672 EFFLUENT PERITONEAL DIALYSIS FLUID TURBIDITY CAN REVEAL COLON CANCER	28
POS-087 MINERAL BONE DISORDERS IN CHILDREN WITH SICKLE CELL ANEMIA AND ACUTE KIDNEY INJURY	28
POS-003 The three C-terminal domains of FHR1 influence complement activation and FHR1 cooperation with other complement regulators	28
Oxidative Stress Contributes to Slit Diaphragm Defects Caused by Disruption of Endocytosis	27
Association Between Maternal Smoking, Isolated Proteinuria During Pregnancy and Preterm Birth: A Finnish Registry Analysis	27
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis	27
WCN23-1039 THE XGBckd MODEL: PREDICT CHRONIC KIDNEY DISEASE IN DIABETES PATIENTS	27

Longitudinal Changes in Kidney Solute Clearance in a Prospective Cohort of Patients Initiating Chronic Hemodialysis	27
High Macrophage Densities in Native Kidney Biopsies Correlate With Renal Dysfunction and Promote ESRD	26
Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective	26
Clinical Real-Time Genome Sequencing to Solve the Complex and Confounded Presentation of a Child With Focal Segmental Glomerulosclerosis and Multiple Malignancies	26
Pregnancy and Family Planning in Women With Kidney Disease	26
Genetically Predicted Body Selenium Concentration and estimated GFR: A Mendelian Randomization Study	26
Fertility Management in Cystinosis: A Clinical Perspective	25
Nephrologists’ Views on a Workflow for Returning Genetic Results to Research Participants	25
Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation	25
Torque Teno Virus-Guided Immunosuppression in Kidney Transplantation: Expanding the Application	25
Dissecting the Obesity Paradox in Patients With Obesity and CKD	25
SARS-CoV-2 Infection Evolution Among Nephrologists During the Pandemic: Clinical Features and Impact of Vaccination	25
Corrigendum to “WCN24-2221 NEPHROCALCINOSIS AND LOWER LIMBS TISSUE NECROSIS DUE TO CALCIUM OXALATE DEPOSITS IN A 24-YEAR-OLD PATIENT WITH STAGE 5 CHRONIC KIDNEY DISEASE” [Kidney International Reports	24
All About ABBA: New Insights Into Antibrush Border Antibody Disease	24
Corrigendum to “Clinicopathological Characteristics of Adult IgA Nephropathy in the United States” [Kidney International Reports Volume 8, Issue 9, September 2023, Pages 1792-1800]	24
Corrigendum to “Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy” [Kidney International Reports Volume 6, Issue 4, April 2021, Pages 1183-1188]	24
Droxidopa for Management of Chronic Hypotension in Hemodialysis	24
WCN23-0595 A MIN-TERM CLINICAL FOLLOW-UP STUDY ON CREATING ARTEIOVENOUS FISTULA BY A MODIFIED NO-TOUCH TECHNIQUE	24
Erratum to “Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition” [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919	24
Dried Blood Spot Sampling for Monitoring Children With Immune-Mediated Glomerulopathies and After Kidney Transplantation	24
Coronaries, Calcium, and Kidney Consequences	23
Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy	23
WCN24-1204 MULTIDIMENSIONAL BURDEN OF CHRONIC KIDNEY DISEASE IN EIGHT COUNTRIES: INSIGHTS FROM THE IMPACT CKD STUDY	23
Response to: “Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study”	23
WCN24-2225 COMPARISON OF HANDHELD VERSUS HIGH-END ULTRASOUND DEVICES FOR THE GUIDANCE OF PERCUTANEOUS KIDNEY BIOPSY	23
Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?	23
WCN24-1498 CHARACTERISTICS OF ADMISSION TO HEMODIALYSIS OF THE PATIENT WITH CHRONIC KIDNEY DISEASE IN SANTA CRUZ-BOLIVIA: A DESCRIPTIVE AND ANALYTICAL OBSERVATIONAL MULTICENTER CROSS-SECTIONAL STUDY	23
WCN24-2081 ATYPICAL MANIFESTATION OF TUBERCULOSIS IN HEMODIALYSIS	22
WCN24-594 REMOTE MONITORING: WHAT REALLY HAPPENS DURING PERITONEAL DIALYSIS?	22
WCN24-2446 EVALUATION OF DISEASE MANAGEMENT AND SELF-CARE NEEDS IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE	22
WCN24-2671 ORCHESTRA (Korean dialysis cohort for mineral, vascular calcification, and fracture) Study: Design, method, and baseline characteristics	22
WCN24-1671 THE METABOLIC VULNERABILITY INDEX, REFLECTING MALNUTRITION AND INFLAMMATION, PREDICTS MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS	22
WCN24-707 QUALITY OF LIFE IN HEMODIALYSIS PATIENTS IN BOLIVIA	22
WCN24-1112 ASSESSMENT AND COMPARISON OF THE QUALITY OF LIFE OF BRAZILIAN AND VENEZUELAN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS TREATMENT IN RORAIMA-BRAZIL	22
WCN24-741 LONG-TERM OUTCOMES OF RENAL TRANSPLANTATION IN CHILDREN WEIGHING LESS THAN 10 KG	21
WCN24-1234 RENAL TUBULE-SPECIFIC NRF2 DELETION ATTENUATES GLOMERULAR HYPERFILTRATION AND KIDNEY INJURY VIA DOWN-REGULATION OF SGLT2 AND ANGIOTENSINOGEN EXPRESSION IN DIABETIC MICE	21
WCN24-2452 A STUDY OF CLINICAL PROFILE AND OUTCOME OF PREGNANCY RELATED ACUTE KIDNEY INJURY IN A TERTIARY CARE CENTER IN SOUTH INDIA	21
WCN24-2135 CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT IN CHILDREN IN TWO HOSPITALS IN DOUALA CAMEROON	21
WCN24-2404 THROMBOTIC MICROANGIOPATHY AS CAUSE OF RENAL GRAFT DYSFUNCTION IN PATIENT WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS AND RESPONSE TO B-CELL ACTIVATING FACTOR I	21
WCN24-797 Roles of Irisin, a myokine on uremic sarcopenia	21
WCN24-455 COMMUNITY HEALTH WORKERS AND CHRONIC KIDNEY DISEASE: A GLOBAL PERSPECTIVE	20
WCN24-861 SUBCLINICAL RHABDOMYOLYSIS IN MESOAMERICAN NEPHROPATHY	20
WCN24-2134 TG/HDL-C ratio as mortality predictor in chronic hemodialysis patients	20
WCN24-2576 ENHACING SAFETY IN TUNNELED HEMODIALYSIS CATHETER INSERTION WITH NON-FLUOROSCOPIC TECHNIQUES	20
WCN24-2440 A PROSPECTIVE STUDY OF ROLE OF" DOUBLE J STENTING" IN UROSEPSIS, PROGRESSING TO SEVERE SEPPSIS IN A TERITIARY CARE CENTER IN RURAL INDIA	20
WCN24-295 COVID-19 AND ACUTE KIDNEY INJURY IN ELDERLY PATIENTS: COMPARATIVE COHORT STUDY BETWEEN THE FIRST AND SECOND WAVES OF THE PANDEMIC IN BRAZIL	20
WCN24-1041 OXIRIS MEMBRANE PERFORMANCE IN PATIENTS WITH SEPTIC SHOCK AND CONTINUOUS KIDNEY REPLACEMENT THERAPY REQUIREMENT: A RANDOMIZED CONTROLLED TRIAL	20
WCN24-2260 A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL FOR CVD IN CKD: STUDY POPULATION CHARACTERISTICS	20
WCN24-2180 The beneficial effects of ω3-PUFA on renal fibrosis via AMPK-mediated autophagy flux	19
Vasopressin for Post-kidney Transplant Hypotension	19
WCN25-3057 Environmentally Informed Prescribing in Kidney Care: An environmental impact scan of a provincial kidney formulary	19
WCN25-1449 FAMILIAL IGA NEPHROPATHY: A PERPLEXING CONUNDRUM IN A FAMILY	19
WCN25-414 EFFECT OF STRUCTURED NUTRITIONAL EDUCATION ON SUBJECTIVE GLOBAL ASSESSMENT SCORES IN HAEMODIALYSIS PATIENTS: A SINGLE CENTRE –PROSPECTIVE OBSERVATIONAL STUDY	19
WCN24-496 THE SIGNIFICANCE OF DETERMINING IMMUNO-NUTRITIONAL INDEXES IN THE ASSESSMENT OF LUPUS NEPHRITIS ACTIVITY	19
Addressing the Multisystemic Impacts of Nephropathic Cystinosis in an Adult	19
WCN25-2239 QUANTITATIVE IMAGE ANALYSIS UNCOVERS THE EFFICACY OF THE SELECTIVE ENDOTHELIN A RECEPTOR ANTAGONIST ATRASENTAN IN A RAT MODEL OF IGA NEPHROPATHY	19
WCN25-1290 A FATAL CASE OF AV FISTULA THROMBOSIS ASSOCIATED WITH PULMONARY THROMBOEMBOLISM IN POST RENAL TRANSPLANT PATIENT	19
WCN25-1583 PREVALENCE AND RISK FACTORS OF INTRADIALYTIC HYPERTENSION IN MALAYSIAN HAEMODIALYSIS PATIENTS: A MUTLI-CENTRE OBSERVATIONAL STUDY	19
WCN25-992 STRATEGIES TO DECREASE HEPATITIS C BURDEN AND IMPROVE SAFETY, COST-EFFECTIVELY IN THE HEALTH SYSTEM AMONG PATIENTS ON HEMODIALYSIS: LESSONS FROM LOW RESOURCE SETTINGS	19
WCN24-933 Effectiveness and safety of Finerenone in Chinese CKD patients without diabetes mellitus: A real-world retrospective study	19
Population Frequency of Undiagnosed Fabry Disease in the General Population	19
WCN24-1742 TOTALLY HARMLESS OR SLOW BURN: HOW DO WE INTERPRET CHANGES IN SERUM CREATININE FROM MOLECULARLY-TARGETED CANCER THERAPIES?	19
WCN25-3072 CLINICAL FEATURES OF 7 PATIENTS UNDER HEMODIALYSIS FOR MORE THAN 20 YEARS IN THE DIALYSIS UNIT OF THE UNIVERSITY HOSPITAL CENTRE OF SAHLOUL	19
WCN25-967 REGULAR USE OF TACROLIMUS GENOTYPE TEST AND USE OF FLUCONAZOLE IN FAST METABOLIZERS TO ACHIVE THERAPEUTIC DRUG LEVELS POST KIDNET TRANSPLANTATION	19
WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients	19
WCN25-1020 Nephrology as the leader in Point of Care Ultrasound (POCUS)	18
WCN25-1896 ONE YEAR OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS IN ZAMBIA - SUBSAHARAN AFRICA	18
WCN25-3972 THE SILENT THREAT: CAN BATTERIES DISCHARGE YOUR KIDNEYS? – A CASE REPORT ON AKI DUE TO OCCUPATIONAL EXPOSURE	18
WCN25-2130 A STUDY TO CORRELATE SERUM PHOSPHORUS WITH MARKER OF ENDOTHELIAL CELL DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTENANCE HAEMODIALYSIS	18
WCN25-989 Challenges and Opportunities in Assessing Kidney Function in Simultaneous Heart-Kidney Transplant Candidates	18
WCN25-1682 STUDY OF MEAN PLATELET VOLUME AND RED CELL DISTRIBUTION WIDTH IN ACUTE KIDNEY INJURY	18
WCN25-3847 AN UNUSUAL CASE OF HSV PNEUMONIA MASQUERADING AS PCP PNEUMONIA IN POST TRANSPLANT PATIENT	18
WCN25-643 THE LIFESAVING JOURNEY FOR CALCIPHYLAXIS: ADDRESSING RAPIDLY PROGRESSIVE ATTACKS WITH MULTIDIMENSIONAL AND AI RESEARCH FOR REGENERATIVE MEDICINE	18
WCN25-4456 GLOMERULOCYSTIC KIDNEY DISEASE: KEY INSIGHTS AND LESSONS LEARNED	18
WCN25-2982 USG guided needle directed thrombolysis of acute AVF thrombosis: A Case Series	18
WCN25-4606 DIAGNOSTIC UTILITY AND CLINICAL IMPACT OF GENOMIC TESTING NI ADOLESCENT AND ADULT KIDNEY DISEASE PATIENTS WITH SUSPECTED MONOGENIC ETIOLOGY – A PRAGMATIC PROSPECTIVE OBSERVATIONAL COHORT ST	18
WCN25-3276 SPECTRUM OF KIDNEY DISEASES IN ADOLESCENT POPULATION: A SINGLE-CENTER STUDY	18
WCN25-4542 Virtual Care is a barrier to sustaining trusting relationships and optimal clinical outcomes for Peritoneal Dialysis patients from Rural and Indigenous Communities	18
WCN25-4221 DEMOGRAPHY AND PRACTICE PATTERN OF END STAGE RENAL DISEASE IN KERALA,INDIA-REPORT FROM TRIVANDRUM DIALYSIS REGISTRY BY TRIVANDRUM NEPHROLOGY CLUB	18
WCN25-4586 Microbiological Evaluation of Urinary samples in A Cohort of Patients with Chronic Kidney Disease: A descriptive study	18

WCN25-2785 UNMET MENTAL HEALTH NEEDS AND CAREGIVER STRAIN IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS	18
WCN25-4220 CAPD IN ESRD AND CLD PATIENTS WITH REFRACTORY ASCITES: A 12-MONTH FOLLOW-UP STUDY	18
WCN25-1541 Comparing the Accuracy of Overhydration Assessment Methods in Hemodialysis and Peritoneal Dialysis Patients: The Potential Future of Wearable BIA Device	17
WCN25-2084 EVALUATION OF TUBULOGLOMERULAR OUTCOME BY MEASURING PROTEINURIA AND URINARY NGAL AFTER INDUCTION BY MMF IN CLASS III/IV LUPUS NEPHRITIS	17
WCN25-2338 POTENTIAL DIAGNOSTIC ROLE OF URINARY EXOSOMAL miRNAS IN IgA NEPHROPATHY: A CLINICAL OBSERVATIONAL STUDY	17
WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY	17
POS-872 Post covid vaccination- new onset glomerulonephritis- a mere co incidence or a impending reality??	17
WCN25-128 SECONDARY HYPERPARATHYROIDISM IN DIALYSIS PATIENTS: SHORT- AND LONG-TERM OUTCOMES OF CONSERVATIVE PARATHYROIDECTOMY	17
WCN25-1435 VISUALIZATION OF THE MESANGIAL-CELL-SURFACE AUTOANTIGENS IN IGA NEPHROPATHY	17
Inside CKD: Cost-Effectiveness of Multinational Screening for CKD	17
WCN25-4378 OUTCOME OF USE OF ENTERIC RELEASED BUDESONIDE IN IgA NEPHROPATHY PATIENTS WITH NEPHROTIC AND SUBNEPHROTIC PROTEINURIA PRESENTATIONS: PROSPECTIVE COMPARATIVE STUDY IN TERTIARY CARE CENTRE	17
Exploring Preconceptions as Barriers to Peritoneal Dialysis Eligibility: A Global Scenario-Based Survey of Kidney Care Physicians	17
WCN25-3017 IMMUNOSUPPRESSION COMBINED WITH TONSILLECTOMY IS EFFECTIVE IN CAUCASIAN PATIENTS WITH HIGH-RISK PRIMARY IGA-NEPHROPATHY	17
WCN23-0373 ALTERNATIVE COMPLEMENT PATHWAY PHARMACODYNAMICS OF IPTACOPAN	17
WCN25-3004 ANTi-NEPHRIN ANTIBODIES IN A LARGE COHORT OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME	17
Higher Symptom Frequency and Severity After the Long Interdialytic Interval in Patients on Maintenance Intermittent Hemodialysis	16
Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories	16
Early Identification of CKD—A Scoping Review of the Global Populations	16
Program Implementation to Achieve Sustainability for Early Detecting of Kidney Diseases and Promoting Kidney Health and Transplantation in Communities	16
Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada	16
POS-486 SECONDARY POLYCYTHEMIA IN NEPHROTIC SYNDROME – AN UNCOMMON ASSOCIATION	16
Ecological Momentary Assessment to Explore Fatigue, Mood, and Physical Activity Levels in People Receiving Peritoneal Dialysis	16
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD	16
A Pilot Study of the Safety and Efficacy of Alkali Therapy on Vascular Function in Kidney Transplant Recipients	16
In-Center Hemodialysis and Patient Travel Time in Aotearoa New Zealand: A Nationwide Geospatial and Data Linkage Study	16
Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease	16
Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant Recipients	16
Use of Glucose-Lowering Agents in Diabetes and CKD	15
Depressive Symptoms at Kidney Transplant Evaluation and Access to the Kidney Transplant Waitlist	15
Metabolic Acidosis Is Associated With an Accelerated Decline of Allograft Function in Pediatric Kidney Transplantation	15
Cost-Minimization Analysis of Tolvaptan Treatment for ADPKD in Southern Spain	15
BK Virus Nephropathy in the Native Kidney of a Liver Transplant Recipient	15
How Was Kidney Care Reshaped by the COVID-19 Pandemic?	15
High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health	15
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study	15
Clinicopathologic Features of IgG4-Related Kidney Disease	15
The “New Caledonia COVID-19 Paradox”: Dramatic Indirect Impact of the Pandemic on Organ Donation and Transplantation in a Nonprevalence Country	15
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis	15
Belatacept Conversion in Adolescent Kidney Transplant Recipients: A Solution for the Critical Challenge of Adherence?	15
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD	15
A Systematic Review of Renal Pathology in Chronic Kidney Disease of Uncertain Etiology	15
What Can Mercury Teach Us About Membranous Nephropathy and Minimal Change Disease?	15
Extracorporeal Therapy for Idiopathic Nephrotic Syndrome	15
Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside	14
Attitudes of the Brazilian Population Toward Organ Donation	14
Deceased-Donor Kidneys: Is Past Performance an Indicator of Future Transplant Success?	14
Two Cases of Double-Positive Antineutrophil Cytoplasmic Autoantibody and Antiglomerular Basement Membrane Disease After BBV152/Covaxin Vaccination	14
Association Between Albuminuria and Glomerular Filtration Rate With Incident Frailty	14
Malakoplakia of the Kidney Transplant	14
Renal impairment in Wilson’s disease	14
Response to Early Detection Matters: Bridging Evidence and Practice, a Call for Enhanced Cardiovascular Screening in ADPKD	14
Renal Prognosis of COVID-19 Associated Nephropathy	14
Urinary Protein-Biomarkers Reliably Indicate Very Early Kidney Damage in Children With Alport Syndrome Independently of Albuminuria and Inflammation	14
Global Disease Burden From Acute Glomerulonephritis 1990–2019	14
B-Cell Depletion in Glomerular and Autoimmune Diseases: Too Much of a Good Thing?	14
A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis	14
Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis	14
Exome-First Strategy in Adult Patients With CKD: A Cohort Study	14
The Role of Mitochondrial Dysfunction in CKD-Related Vascular Calcification: From Mechanisms to Therapeutics	14
Apheresis in Adult With Refractory Idiopathic Nephrotic Syndrome on Native Kidneys	14
Is it Time to Expand the Use of SGLT2 Inhibitors in Kidney Transplant Recipients?	14
A Narrative Review of Dietary Approaches for Kidney Transplant Patients	14
The Promise of Metabolomics and Exposomics in CKDu	13
WCN25-4040 SYSTEMATIC REVIEW OF STRATEGIES TO INCREASE UPTAKE OF COMPREHENSIVE CONSERVATIVE CARE FOR ADVANCED CHRONIC KIDNEY DISEASE PATIENTS	13
Clinical Relevance of Anti-C3 and Anti-C4 Autoantibodies in Lupus Nephritis	13
POS-132 TRIAL DESIGN: PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NARSOPLIMAB SAFETY AND EFFICACY IN IGA NEPHROPATHY (ARTEMIS-IGAN)	13
WCN23-0517 Presentation Title: A CASE OF COMPLICATED INTESTINAL CALCIPHYLAXIS WITH NO CUTANEOUS LESIONS	13
Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis	13
POS-476 MESANGIAL HYPERCELLULARITY AS A VARIANT OF MINIMAL CHANGE DISEASE: A SERIES OF 4 PATIENTS	13
The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria	13
Monogenic Kidney Diseases in Kidney Transplantation	13
Effects of Medications on the in vitro Growth of Gut Bacteria Associated With Kidney Stones	13
WCN23-0915 CKMBD PROFILE OF PATIENTS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS	13
WCN23-0024 MANAGEMENT AND OUTCOME OF RECIPIENT RENAL TRANSPLANTATION FROM A TUBERCULOSIS POSITIVE DONOR	13
Outcome and Determinants of Outcome of COVID-19 Infection Among Hemodialysis Patients: Findings From a National Dialysis Network Program in India	13
Early Stops on the Road to Transplant: Lessons From the German Transplantation Registry	13
Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy	13
Transjugular Kidney Biopsy as a Safe Method to Increase the Etiological Diagnosis in Kidney Disease	13
Masked Arginine Vasopressin Deficiency in a Kidney Transplant Recipient With Posttransplant Lymphoproliferative Disorder	13
WCN23-0922 ASSOCIATION OF ORAL HEALTH HYGIENE AND PERITONITIS WITH NON-ENTEROCOCCAL STREPTOCOCCI OF PATIENTS ON PERITONEAL DIALYSIS: A FINDING FROM MycoPDICS DATABASE	13
WCN23-0251 ROLE OF RETICULOCYTE-HEMOGLOBIN IN PREDICTING HEMOGLOBIN CHANGES IN PATIENTS WITH ANEMIA UNDERGOING MAINTENANCE HEMODIALYSIS	13
New Insights Regarding Organ Transplantation in Primary Hyperoxaluria Type 1	13
POS-587 RELATIONSHIP BETWEEN DURATION OF ROUTINE HEMODIALYSIS WITH CALCIUM PHOSPHATE PRODUCTS IN CHRONIC KIDNEY DISEASE PATIENTS IN DR. RAMELAN NAVAL CENTRAL HOSPITAL SURABAYA	12
POS-754 PERSISTENT HYPERPARATHYROIDISM AFTER KIDNEY TRANSPLANTATION, ITS PREVALENCE AND RISK FACTORS	12
WCN23-0585 THE FIRST CASE DNAJB11 ASSOCIATED NEPHROPATHY IN GREECE (AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE-6/ ADPKD-6)	12
WCN25-79 NON-INVASIVE DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY MACHINE-LEARNING BASED EVALUATION OF URINARY EXFOLIATED PROXIMAL TUBULE CELL MULTISPECTRAL AUTOFLUORESCENCE	12
POS-086 INH INDUCED LACTIC ACIDOSIS IN HEMODIALYSIS PATIENT NOT COMPLIANT WITH HEMODIALYSIS AND PYRIDOXIN	12
POS-151 USE OF RITUXIMAB IN PAEDIATRIC STEROID SENSITIVE NEPHROTIC SYNDROME: A COST-BENEFIT PERSPECTIVE	12
POS-799 Experimental study to evaluate the impact of structured education program in kidney transplantation among the nurses to improve the work efficiency and quality patient care	12
POS-499 Thirst Intensity Survey in ADPKD patients	12
Corrigendum to “Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease”Kidney International Reports, Volume 7, Issue 4, Ap	12
WCN23-1217 CLINICOPATHOLOGIC CHARACTERIZATION OF FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS IN A DOMINICAN REPUBLIC SAMPLE	12
POS-822 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2i); SHORT-TERM OUTCOME IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS	12
POS-890 SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SYNDROME REVEALING PLASMA-CELL LEUKEMIA IN A COVID-19 PATIENT PRESENTING WITH KIDNEY INJURY	12
POS-014 THE RELATIONSHIP BETWEEN IL-6, IL-10, TNF-α WITH AKI IN MODERATE AND SEVERE COVID-19 PATIENTS	12